Head of preclinical development at Imbrium Therapeutics
Sleep Disturbances and Recovering From Alcohol Use Disorder: Garth T. Whiteside, PhD
The head of preclinical development at Imbrium Therapeutics provided an overview of positive safe and efficacy findings from the phase 2 study investigating sunobinop. [WATCH TIME: 4 minutes]